Xuezhikang capsule (ethanol extract of red yeast rice) which produced by Beijing WBL Peking University Biotech Co., Ltd., is a traditional Chinese medication with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibiting activity. Clinical trials indicated that Xuezhikang with lipid-lowering action could reduce the risk of cardiac events and total mortality of Chinese coronary heart disease patients. To exactly explain the clinical features of Xuezhikang, we undertook a complete study of the chemical constituents of Xuezhikang. This study resulted in the isolation of a new monacolin analogue, named alpha, beta-dehydromonacolin L (1), along with two known compounds: monacolin L (2) and 3-(2, 6-dimethyl-1, 2, 4a, 5, 6, 7, 8, 8a-octahydronaphthalen-1-yl)propanoic acid (3). The chemical structures were determined by extensive 1D and 2D NMR and MS spectroscopic analysis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Structural Elucidation and Complete NMR Spectral Assignments of Monascus Monacolin Analogs.
Magn Reson Chem
February 2025
Ocean College, Zhejiang University, Zhoushan, China.
Article Synopsis
- - Three new compounds related to monacolin were discovered from red yeast rice extract: monacolin V, 6-hydroxyl monacolin P, and 3-keto monacolin S.
- - The structures of these compounds were identified using high-resolution mass spectrometry (HRESIMS) and nuclear magnetic resonance (NMR) techniques.
- - This research marks the first complete assignment of NMR data for the new compounds 6-hydroxyl monacolin P and 3-keto monacolin S.
Structural elucidation and complete NMR spectral assignments of Monascus monacolin analogues.
Magn Reson Chem
August 2024
Ocean College, Zhejiang University, Zhoushan, China.
Three new monacolin analogues, 3,6-dihydroxy-monacolin P (1), 6-methoxy monacolin S (2), and 6-methoxy dehydromonacolin S (3), were isolated from a fraction that strongly inhibited 3-hydroxy-3-methylglutaryl-CoA reductase from the ethyl acetate portion of red yeast rice ethanol extract. Their structures were determined through a combination of 1D and 2D NMR experiments, mass spectrometry analysis, and known literature reports.
View Article and Find Full Text PDFExpanding the Substrate Scope of Acyltransferase LovD9 for the Biosynthesis of Statin Analogues.
Chemistry
July 2023
Center for cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo de Miramón, 182, 20014, Donostia-San Sebastián, Spain.
This study identifies new acyl donors for manufacturing statin analogues through the acylation of monacolin J acid by the laboratory evolved acyltransferase LovD9. Vinyl and p-nitrophenyl esters have emerged as alternate substrates for LovD9-catalyzed acylation. While vinyl esters can reach product yields as high as the ones obtained by α-dimethyl butyryl-S-methyl-3-mercaptopropionate (DMB-SMMP), the thioester for which LovD9 was evolved, p-nitrophenyl esters display a reactivity even higher than DMB-SMMP for the first acylation step yet the acylation product yield is lower.
View Article and Find Full Text PDFEffects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.
Semergen
September 2022
Lipid Unit and Vascular Risk. Internal Medicine Department Bellvitge University Hospital-IDIBELL, Spain; CIBEROBN, Spain; Universidad de Barcelona, Spain.
Objective: The use of nutritional supplements to treat hypercholesterolemia is gradually increasing, however further studies on their efficacy and safety are required.
Patients And Methods: The present clinical trial included patients with moderate hypercholesterolemia and cardiovascular risk who were treated either with a nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®) or with a placebo.
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice.
Cardiovasc Ther
June 2021
Department of Medicine (DIMED), University of Padova, Italy.
Background And Aims: A relevant role is emerging for functional foods in cardiovascular prevention. The aim of this study was to assess the effect of a nutraceutical multitargeted approach on lipid profile and inflammatory markers along with vascular remodelling in a cohort of dyslipidemic subjects without history of cardiovascular (CV) disease.
Methods And Results: We enrolled 25 subjects (mean age 48.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!